Previous studies from our laboratory have shown that a high dose of cryptococcal culture filtrate antigen (CneF) administered intravenously induces a complex suppressor cell cascade which down-regulates the cell-mediated immune response to Cryptococcus neoformans antigens. The primary objective of this investigation was to determine whether a suppressor cell induced by immunization is required for efferent suppression of the cryptococcal delayed-type hypersensitivity (DTH) response. Our approach to this problem was to immunize CBA/J mice with CneF emulsified in complete Freund adjuvant and then 6 days later to collect spleen cells from the immunized mice and adoptively transfer these cells along with C. neoformans-specific second-order suppressor T cells (Ts2) to naive syngeneic recipients at the time of footpad challenge of the recipients with CneF. To establish which populations of cells in the spleens of immunized mice play a suppressive role, mass cytolysis with specific antibodies and complement was performed before the spleen cells were transferred to naive animals. Since the phenotype of the cells responsible for the transfer of the cryptococcal DTH response had not been completely determined, we first demonstrated that the cells responsible for DTH were L3T4+ Lyt-2-cells. Subsequently, we established that a Thy-l+ L3T4-Lyt-2+ I-J+ cell population induced by immunization was required along with C. neoformans-specific Ts2 cells for efferent suppression of the cryptococcal DTH response. In addition, we demonstrated that the suppressor cells in the immune cell population were derived from cyclophosphamide-sensitive precursors. These data indicate that a third suppressor cell population is required for efferent suppression of the cryptococcal DTH response. As in the azobenzenearsonate and 4-hydroxy-3-nitrophenyl acetyl hapten suppressor models, the Ts2 cells in the circuit mediate their effects through this third suppressor component. Since the mode of induction and the phenotype of the third C. neoformans-specific suppressor cells are similar to those reported for Ts3 cells in other antigen-specific suppression models, we referred to this third suppressor cell in the C. neoformans-specific suppressor cell cascade as a Ts3 cell.
Cryptococcosis is a fungal disease caused by an encapsulated yeastlike organism, Cryptococcus neoformans. Depressed cell-mediated immunity and high levels of cryptococcal antigen in body fluids are common coexisting findings in patients with progressive or disseminated cryptococcosis (6, 11, 31) . Using a murine model, we have demonstrated a direct correlation between high cryptococcal antigen titers and depressed delayed-type hypersensitivity (DTH) responses (16, 17) . Intravenous (i.v.) injection of mice with 20 p,g to 1 mg of cryptococcal culture filtrate antigen (CneF) triggers the induction of a cascade of C. neoformans-specific suppressor cells and factors (23, 24, (26) (27) (28) . Briefly, the sequence of events is as follows. At 7 days after CneF administration, a Lyt-1+ I-J+ first-order suppressor T-cell (Tsl) population is induced in lymph nodes from a cyclophosphamide (Cy)-sensitive precursor (24, 26, 28) . Tsl cells or the soluble factor derived therefrom, i.e., TsF1, injected at the time of immunization specifically suppress the cryptococcal DTH response by inhibiting the production of cells responsible for the response (TDH cells) (24, 26, 28) . In addition, both Tsl cells and TsF1 induce second-order T suppressor cells (Ts2) (27) . Ts2 cells, which are found in the spleens of animals given Tsl cells or TsF1, are induced from Cy-resistant precursors, are Lyt-1--2+ I-J+, and are efferent suppressors (27) . Ts2 cells mediate suppression by means of a soluble factor (TsF2) (27) . The features of the C. neoformans-suppressive pathway that have been studied resemble the suppressive circuits that * Corresponding author. modulate the DTH responses to the haptens azobenzenearsonate (ABA) and 4-hydroxy-3-nitrophenyl acetyl (NP) (1, 3, 8, 9, 12, 22, 29, 30, 33, 34, 38, 39) . In these two hapten models, as well as in certain other antigen-specific suppressor cell circuits, a third-order suppressor cell (Ts3) population induced by an immunization protocol has been defined (1-3, 8, 12, 13, 21, 22, 29) .
The primary purpose of this study was to determine whether a cell similar to the Ts3 cell in other models is required in the C. neoformans-specific suppressor cell pathway. To make this assessment, further characterization of the TDH cells was necessary. TDH cells can be detected by adoptive transfer of spleen cells from mice that have been immunized 6 days earlier with CneF in complete Freund adjuvant (CneF-CFA). Through adoptive transfer experiments, the phenotype of the TDH cells was shown to be L3T4+ Lyt-2-. In similar transfer studies in which spleen cells from immunized mice were adoptively transferred to naive syngeneic mice along with C. neoformans-specific Ts2 cells, the transferred DTH was significantly suppressed. On the other hand, when Lyt-2+ cells were removed by mass cytolysis with anti-Lyt-2.1 antibody and complement from the immune spleen cell pool and transferred along with Ts2 cells, efferent suppression was abrogated. These results indicate that Lyt-2+ cells in the sensitized cell population are necessary for Ts2-mediated suppression of the cryptococcal DTH response. The suppressor cells in the immune population were further characterized as Thy-1+ I-J+ cells and were shown to be derived from Cy-sensitive precursors. Considering that the suppressor cells induced by immunization with 1658 KHAKPOUR AND MURPHY CneF-CFA are phenotypically and functionally similar to Ts3 cells which have been described in other antigen-specific suppressor cell pathways (1, 3) , the suppressor cells induced by immunization with CneF-CFA are referred to as C. neoformans-specific Ts3 cells.
MATERIALS AND METHODS
Mice. Male and female CBA/J mice (H-2k Lyt-1.1 Lyt-2.1) purchased from Jackson Laboratory, Bar Harbor, Maine, were used at 7 to 10 weeks of age throughout these studies.
Antigen. CneF used for induction of suppression, immunization, and footpad challenge was prepared by the procedure described by Cauley and Murphy (4) . Briefly, C. neoformans 184-A (25) was grown for 3 days in a neopeptone-dialysate broth supplemented with glucose and thiamine hydrochloride. After the cultures were treated with 2% Formalin for 18 h, the cells were removed by centrifugation and filtration, and the supernatant was then washed and concentrated on a membrane filter with a 50,000-molecular-weight exclusion limit (XM50 membrane; Amicon Corp., Lexington, Mass.). The CneF used in these studies had a protein concentration of 5.0 mg/ml, measured by the procedure of Lowry et al. (18) as modified by Miller (19) , and a carbohydrate concentration of 2.4 mg/ml, based on results of the phenol-sulfuric acid assay (10 Antibody treatment of spleen cells. The anti-Thy-1 antibody used in these studies has been previously described (26 (28) . Anti-L3T4 monoclonal antibody was a culture supernatant produced from the GK 1.5 hybridoma obtained from the American Type Culture Collection, Rockville, Md., and was used at a 1/10 dilution. In all antibody treatments, 0.1 ml of antibody was added to 108 spleen cells. After the cells and antibody were incubated at room temperature for 30 min, the cells were washed once with Hanks balanced salt solution and suspended in the complement source which was 0.1 ml of 3% rabbit serum (28) made up with guinea pig serum diluted 1/16 (28) . After 30 min of incubation at 37°C, the cells were extensively washed and suspended in 0.5 ml of Hanks balanced salt solution per 108 cells treated. Mice were injected i.v. with 0.5 ml of the treated cell suspension. To assure the efficacy of the antibody and complement treatments, prior to being used in these studies, the designated dilutions of each antibody along with the complement source described above were shown to abrogate specific immune functions known to be associated with specific cell phenotypes. For example, treatment of C. neoformans-specific Ts2 cells with anti-IlJk or anti-Lyt-2.1 antibody and complement ablated their efferent suppressive activity, and the anti-L3T4 and complement abrogated C. neoformansspecific Tsl cell-mediated suppression.
Adoptive transfers. For adoptive transfer experiments, five donors were used for five recipients. In certain experiments, 108 sensitized spleen cells either untreated or after treatment with the appropriate antibody and complement were adoptively transferred i.v. to naive syngeneic recipients. In other experiments, specified groups of mice were given 108 untreated or treated sensitized spleen cells and 108 Ts2 cells. Within 1 h after cell transfers, the footpads of recipient mice were challenged with 30 pLI of CneF, and the footpads were measured 24 h later.
Cy treatment. In studies to investigate the Cy sensitivity of the Ts3 cell precursors, mice were injected intraperitoneally 2 days before immunization with Cy (100 mg/kg of body weight) obtained from Sigma Chemical Co., St. Louis, Mo. At 6 days after immunization, the spleen cells of the Cytreated immunized mice were assayed for the presence of suppressor cells, i.e., Ts3 cells, by adoptively transferring spleen cells from Cy-treated immune mice along with Ts2 cells to naive syngeneic recipients before footpad challenge.
Statistical analysis. Calculations of means, standard errors of the mean, and unpaired Student's t tests were used to analyze the data.
RESULTS
Further characterization of C. neoformans-specific TDH cells. In previous studies, we have shown that C. neoformans-specific TDH cells are not destroyed by treatment with anti-Lyt-2.1 antibody and complement (24) . Considering that L3T4 antigen does not coexist with Lyt-2 antigen on mature T cells (5, 32) , one might assume that the C. neoformansspecific TDH cells are L3T4+. To confirm this, spleen cells collected 6 days after immunization with CneF-CFA were treated with anti-L3T4 or anti-Lyt-2.1 antibody and complement and then adoptively transferred i.v. to naive recipients. The recipients were footpad challenged with CneF, and footpad swelling was measured 24 h later. The results of one such experiment are shown in Fig. 1 8, 9, 12, 21, 22, 29) . To ascertain which situation exists in the C. neoformans-specific suppressor cell pathway, sensitized spleen cells treated with anti-Lyt-2.1 and complement were adoptively transferred to naive recipients along with Ts2 cells. Recipients were footpad challenged within 1 h after cell transfer with 30 ,ul of CneF, and 24 h later the footpad thicknesses were measured. As shown in Fig. 2 , suppression of the DTH response was demonstrated in mice which received untreated sensitized spleen cells and Ts2 cells (group 3), whereas no significant suppression was detected in mice which received Ts2 cells and sensitized cells that had been treated with anti-Lyt-2.1 antibody and complement (group 4). Furthermore, as we showed in the previous experiment (Fig. 1) As expected, when Lyt-2+ cells fromn sensitized mice were added back, the DTH responses in the recipients (group 5) were suppressed when compared with the positive controls (group 2). However, if the sensitized spleen cell population providing the putative Ts3 cells was treated with anti-Thy-1 and complement prior to transfer (group 6), the suppression was abrogated. These data clearly demonstrate that L3T4-Lyt-2+ T cells in the sensitized cell population are needed for Ts2-mediated suppression.
In general, suppressor T cells of antigen-specific suppressor cell circuits have been shown to express I-J determinants on their surface (1, 3, 8, 12, 21, 36) . To determine whether the T cells in the sensitized spleen cell population required for Ts2-mediated suppression of the cryptococcal DTH response were I-J-bearing cells, we treated sensitized spleen cells with anti-I-J antibody and complement before adoptively transferring the cells to naive recipients. As can be seen by the results from one such experiment (Fig. 4) , the DTH response was suppressed in group 3 mice which received Ts2 cells and sensitized spleen cells pretreated with NMS and complement. In contrast, animals in group 4 Cy sensitivity of the precursor of the suppressor cells in the sensitized cell population. To assess whether the precursors of the suppressor cells in the sensitized spleen cell population were sensitive to Cy, mice were treated with Cy (100 mg/kg of body weight) 2 days before immunization. At 6 days after immunization, sensitized spleen cells from the Cy-treated immunized mice were transferred to naive recipients. Within 1 h after the adoptive transfers, recipients were footpad challenged with CneF, and 24 h later the footpads were measured. In these experiments, animals that received spleen cells from Cy-treated nonimmune animals (Fig. 5,  group 3 ) served as the negative controls, and mice that received spleen cells from Cy-treated immune mice (group 4) served as the positive DTH controls. These special controls for the Cy experiments were not significantly different from the routine negative (group 1) and positive (group 2) controls. Animals in group 5, given (i) 108 (1, 3, 8, 9, 12, 13, 20, 35, 37, 39) . Although there are many similarities among these various complicated circuits, there also appear to be some differences. The C. neoformans-specific suppressor pathway that affects the cell-mediated immune response to cryptococcal antigen and thus has the potential to play a role in an infectious disease process, as defined thus far, resembles the NP-and ABA-specific suppressor circuits regulating the hapten cell-mediated immune responses (1, 8) . For example, in all three of these models, antigen-specific Tsl cells are induced by i.v. administration of haptencoupled spleen cells or antigen (8, 24, 26, 28, 29, 33, 38) . The Tsl cells or TsF1 bind to the specific antigens and specifically suppress the DTH response when given to recipients at the time of immunization (1, 8, 9, 24, 28, 38) . Another similarity in these models is that Tsl cells or TsFl induce Ts2 cells without a second antigen stimulation which seems to be required in certain other models (1, 3, 8, 9, 27, 28, 30, 37, 39) . Ts2 cells or TsF2 in the NP and ABA systems are anti-idiotypic and thus do not bind the specific antigen but do mediate specific suppression at the efferent phase of the DTH response (8, 9, 29, 30, 33, 37, 39) . The anti-idiotypic characteristic of the C. neoformans-specific Ts2 cells has not been determined; however, we have demonstrated that C. neoformans-specific TsF2 does not bind cryptococcal antigens (23) but Ts2 cells do specifically suppress the cryptococcal DTH response (27) , leading us to predict that the Ts2 cells in the cryptococcal model may be anti-idiotypic also. The Ts2 cells or TsF2 in the NP or ABA models do not directly interact with the TDH cells to suppress the NP or ABA DTH responses but require a Ts3 cell that is found in mice immunized with a subcutaneous injection of the respective antigen-conjugated spleen cells (3, 8, 21, 29, 33) . The need for a suppressor cell induced by an immunizing protocol is not unique to the NP and ABA suppressor cell pathways. Sy et al. (35) showed that contact sensitivity to 1-fluoro-2,4-dinitrobenzene (DNFB) in recipients of lymphoid cells from Cy-treated DNFB-immunized mice cannot be suppressed by a population of DNFB suppressor cells, whereas the contact sensitivity response in recipients of DNFB-immune lymphoid cells is readily suppressed by the same DNFB suppressor cells. These investigators referred to these Cy-sensitive suppressor cells stimulated by the standard immunization protocol as T auxiliary cells (35) . The T auxiliary cells and Ts3 cells described for the NP and ABA models appear to be similar (1, 8) . The phenotype of the NP and ABA Ts3 cells has been reported to be Lyt-2+ I-J+ (1, 8) .
In the present study, we investigated whether Ts2-mediated suppression of the cryptococcal DTH response was evident in recipients which received C. neoformans-specific Ts2 cells and untreated spleen cells from C. neoformans-immunized mice. However, the suppression was abrogated when Ts2 cells were transferred to naive recipients with sensitized cells which had been treated with anti-Lyt-2.1 and complement (Fig. 2) but not when Ts2 cells were transferred to naive recipients with sensitized cells which had been treated with anti-L3T4 antibody and complement (Fig. 3, group 5 ), indicating that L3T4-Lyt-2+ cells in the sensitized cell population were required for the C. neoformans-specific Ts2-mediated suppression. Furthermore, mice which received Ts2 cells in conjunction with sensitized cells treated with anti-I-J antibody and complement showed no suppression of the cryptococcal DTH response (Fig. 4) , demonstrating that sensitized cells from the spleens of immune mice needed for efferent suppression were I-J+. Additional experiments were conducted to confirm that the cells in the immune population involved in efferent suppression of the DTH response were T cells (Fig.  3) . Suppression was only achieved when recipients were supplied with TDH cells, Ts2 cells, and a sensitized cell population containing Lyt-2+ T cells (Fig. 2 and 3) .
In studies in which mice were treated with Cy 2 days before immunization, it was clearly demonstrated that Cy treatment did not affect the development of the TDH-cell population but it inhibited the induction of the suppressor cells (Fig. 5) . Therefore, the C. neoformans-specific suppressor cells induced by immunization with CneF were similar to the T auxiliary suppressor cells described by Sy et al. (35) .
Based on the above data, it was apparent that Ts2 cells and a population of T cells induced as the consequence of immunization were needed for the Ts2-mediated suppression of the cryptococcal DTH response. Furthermore, the L3T4-Lyt 2+ I-J+ suppressor T-cell population induced by immunization with CneF and derived from Cy-sensitive precursors appears to be comparable to the Ts3 cells in the NP and ABA suppressor cell cascades (1, 8, 9, 12) and the T auxiliary cells in the DNFB model (35) .
